These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23992266)

  • 21. Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosis.
    Yanaba K; Asano Y; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2013 Jan; 305(1):17-23. PubMed ID: 23053221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Yanaba K; Komura K; Kodera M; Matsushita T; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients.
    Cossu M; Andracco R; Santaniello A; Marchini M; Severino A; Caronni M; Radstake T; Beretta L
    Rheumatology (Oxford); 2016 Jun; 55(6):1112-6. PubMed ID: 26989111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased serum soluble CD40 levels in patients with systemic sclerosis.
    Komura K; Fujimoto M; Matsushita T; Yanaba K; Kodera M; Kawasuji A; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2007 Feb; 34(2):353-8. PubMed ID: 17295440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort.
    Bournazou E; Samuels J; Zhou H; Krasnokutsky S; Patel J; Han T; Bencardino J; Rybak L; Abramson SB; Junker U; Brown KS; Attur M
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased serum soluble OX40 in patients with systemic sclerosis.
    Komura K; Yoshizaki A; Kodera M; Iwata Y; Ogawa F; Shimizu K; Wayaku T; Yukami T; Murata M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2359-62. PubMed ID: 18843780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Vardas E; Dimoulios P; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):405-8. PubMed ID: 11943954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
    Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
    Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis.
    Ogawa F; Shimizu K; Muroi E; Hara T; Hasegawa M; Takehara K; Sato S
    Rheumatology (Oxford); 2006 Jul; 45(7):815-8. PubMed ID: 16449367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
    Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
    Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis.
    Toyama T; Asano Y; Takahashi T; Aozasa N; Akamata K; Noda S; Taniguchi T; Ichimura Y; Sumida H; Tamaki Z; Masui Y; Tada Y; Sugaya M; Sato S; Kadono T
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):337-44. PubMed ID: 22211766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease.
    Wuttge DM; Wildt M; Geborek P; Wollheim FA; Scheja A; Akesson A
    Arthritis Res Ther; 2007; 9(5):R85. PubMed ID: 17784951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.